Samarth Kulkarni
Director; Director, Chief Executive Officer · 8 filings · Latest: Jun 26, 2026
Black Diamond Therapeutics, Inc.
Centessa Pharmaceuticals plc
CRISPR Therapeutics AG
Oruka Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Mar 23, 2026 | Sale | $46.78 | 10,020 | $468.7K | 255,501 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Mar 20, 2026 | Option Exercise | — | 19,687 | — | 265,521 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Mar 16, 2026 | Sale | $48.26 | 10,349 | $499.4K | 245,834 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Mar 14, 2026 | Option Exercise | — | 20,625 | — | 256,183 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Mar 11, 2026 | Sale | $52.80 | 9,798 | $517.3K | 235,558 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Mar 10, 2026 | Option Exercise | — | 19,250 | — | 245,356 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Feb 19, 2026 | Sale | $52.58 | 6,967 | $366.3K | 226,106 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Feb 18, 2026 | Option Exercise | — | 13,250 | — | 233,073 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Jan 22, 2026 | Sale | $60.23 | 60,000 | $3.6M | 134,201 | |
CRSP | Samarth Kulkarni | Director, Chief Executive Officer | Jan 20, 2026 | Sale | $51.75 | 30,000 | $1.6M | 194,201 | |
CRSP | Samarth Kulkarni | — | Jan 22, 2026 | Proposed Sale | $60.81 | 60,000 | $3.6M | — | |
CRSP | Samarth Kulkarni | — | Jan 20, 2026 | Proposed Sale | $52.61 | 30,000 | $1.6M | — | |
CRSP | Samarth Kulkarni | — | Feb 18, 2025 | Proposed Sale | $52.22 | 45,000 | $2.3M | — | |
CRSP | Dr. Samarth Kulkarni | — | Nov 11, 2024 | Proposed Sale | $54.86 | 75,000 | $4.1M | — |